Longeveron Stock (NASDAQ: LGVN) stock price, news, charts, stock research, profile.
Open | - |
Close | - |
Volume / Avg. | 8.654K / 2.201M |
Day Range | - - - |
52 Wk Range | 0.771 - 40.000 |
Market Cap | $6.029M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 29 |
Short Interest | 1.05% |
Days to Cover | 1 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Longeveron (NASDAQ: LGVN) through any online brokerage.
Other companies in Longeveron’s space includes: Alzamend Neuro (NASDAQ:ALZN), Entero Therapeutics (NASDAQ:ENTO), Synaptogenix (NASDAQ:SNPX), Geovax Labs (NASDAQ:GOVX) and NexImmune (NASDAQ:NEXI).
The latest price target for Longeveron (NASDAQ: LGVN) was reported by HC Wainwright & Co. on Friday, May 17, 2024. The analyst firm set a price target for 12.00 expecting LGVN to rise to within 12 months (a possible 1163.29% upside). 3 analyst firms have reported ratings in the last year.
The stock price for Longeveron (NASDAQ: LGVN) is $0.9499 last updated Today at June 12, 2024 at 4:16 AM EDT.
There are no upcoming dividends for Longeveron.
Longeveron’s Q2 earnings are confirmed for Friday, August 9, 2024.
There is no upcoming split for Longeveron.
Longeveron is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.